Regulatory Affairs in the Pharmaceutical Industry
eBook - ePub

Regulatory Affairs in the Pharmaceutical Industry

  1. 286 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Regulatory Affairs in the Pharmaceutical Industry

About this book

Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed by the pharmaceutical industry. Designed to impart advanced knowledge and skills required to learn the various concepts of regulatory affairs, the content covers new drugs, generic drugs and their development, regulatory filings in different countries, different phases of clinical trials, and the submission of regulatory documents like IND (Investigational New Drug), NDA (New Drug Application) and ANDA (Abbreviated New Drug Application). Chapters cover documentation in the pharmaceutical industry, generic drug development, code of Federal Regulation (CFR), the ANDA regulatory approval process, the process and documentation for US registration of foreign drugs, the regulation of combination products and medical devices, the CTD and ECTD formats, and much more. - Updated reference on drug approval processes in key global markets - Provides comprehensive coverage of concepts and regulatory affairs - Presents a concise compilation of the regulatory requirements of different countries - Introduces the fundamentals of manufacturing controls and their regulatory importance

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Regulatory Affairs in the Pharmaceutical Industry by Javed Ali,Sanjula Baboota in PDF and/or ePUB format, as well as other popular books in Medicine & Operations. We have over one million books available in our catalogue for you to explore.

Information

Year
2021
Print ISBN
9780128222119
eBook ISBN
9780128222232
Subtopic
Operations

Table of contents

  1. Cover
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Dedication
  6. Contents
  7. List of contributors
  8. Editor biographies
  9. Preface
  10. List of Illustrations
  11. List of Tables
  12. Chapter 1 : Drug regulatory affairs: an introduction
  13. Chapter 2 : Regulatory requirement for the approval of novel, nanotechnology-based biological products
  14. Chapter 3 : International Council for Harmonisation (ICH) guidelines
  15. Chapter 4 : Regulatory affairs for chemistry, manufacturing, and controls
  16. Chapter 5 : Global submissions for drug approvals
  17. Chapter 6 : Regulatory requirements of regulated market
  18. Chapter 7 : Pharmaceutical regulatory requirements of nonregulated markets
  19. Chapter 8 : Drug product performance and scale-up process approval changes
  20. Chapter 9 : Regulatory affairs in clinical trials
  21. Index
  22. A